Research Progress on Downstream Mechanisms of Glucose Metabolic Reprogramming and Its Role in the Occurrence and Progression of Type 2 Diabetes Mellitus
Open Access
- 24 June 2026
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 14 (7) , 1427
Abstract
Type 2 diabetes mellitus (T2DM) is a highly prevalent and devastating chronic metabolic disease worldwide, with pathogenesis centrally characterized by insulin resistance and pancreatic β-cell dysfunction. Accumulating evidence has demonstrated that glucose metabolic reprogramming represents an adaptive metabolic shift from oxidative phosphorylation to aerobic glycolysis in cells in response to a hyperglycemic microenvironment. This shift acts as an upstream important event driving the initiation and progression of T2DM. This review summarizes the characteristics of glucose metabolic reprogramming in insulin-sensitive target organs under T2DM conditions, including the liver, skeletal muscle, adipose tissue and pancreatic β-cells. It also discusses four major downstream effector mechanisms: mitochondrial energy metabolism disturbance, augmented oxidative stress, disruption of mitochondria-associated endoplasmic reticulum membranes (MAMs) coupled with calcium homeostasis imbalance, and systemic inflammatory response. On this basis, we summarize the intervention strategies targeting the above signaling pathways, including antioxidant therapy, restoration of MAMs integrity and calcium homeostasis, systemic anti-inflammatory intervention, and multi-target regulatory effects of traditional Chinese medicine. Current studies indicate that early intervention in downstream stress events is induced by glucose metabolic reprogramming. This is particularly true for the preservation of MAMs’ integrity; restoration of calcium homeostasis; and inhibition of NLRP3 inflammasome activation, the latter of which is expected to block or delay the progression from prediabetes to clinical T2DM. Nevertheless, substantial gaps still remain in the understanding of the dynamic regulatory mechanisms of MAMs, tissue-specific therapeutic targets, and relevant clinical translational research. Future integration of multi-omics technologies will provide novel therapeutic strategies and theoretical foundations for the early prevention and treatment of T2DM.Keywords
All Related Versions
Funding Information
- National Administration of Traditional Chinese Medicine Young Qi Huang Scholars Support Project
- Fundamental Research Funds for the Central Universities (2023-JYB-JBZD-010)
- China Postdoctoral Science Foundation (GZC20230324)
- China Postdoctoral Science Foundation (2024M75026)
- Postgraduates of Dongzhimen Hospital, Beijing University of Chinese Medicine (DZMYJS2026006)
This publication has 171 references indexed in Scilit:
- Tea Polyphenol Modulates Mitochondria‐Associated Endoplasmic Reticulum Membrane of Hippocampal Neurons Targeting Grp75 to Ameliorate Memory Impairment in the Aged T2DM RatsFood Science & Nutrition, 2025
- Impact of positive CD4 cells on event‐free survival in follicular lymphoma patientsCancer Medicine, 2024
- M2 Macrophage‐Derived sEV Regulate Pro‐Inflammatory CCR2 + Macrophage Subpopulations to Favor Post‐AMI Cardiac RepairAdvanced Science, 2023
- Potentiation of Lipotoxicity in Human EndoC‐βH1 β‐Cells by Glucose is Dependent on the Structure of Free Fatty AcidsMolecular Nutrition & Food Research, 2023
- IGF-1 ameliorates streptozotocin-induced pancreatic β cell dysfunction and apoptosis via activating IRS1/PI3K/Akt/FOXO1 pathwayInflammation Research, 2022
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 DiabetesJAMA Cardiology, 2021
- AKAP1 mediates high glucose‐induced mitochondrial fission through the phosphorylation of Drp1 in podocytesJournal of Cellular Physiology, 2020
- Molecular mechanisms by which aerobic exercise induces insulin sensitivityJournal of Cellular Physiology, 2019
- CLPTM1L/CRR9 ectodomain interaction with GRP78 at the cell surface signals for survival and chemoresistance upon ER stress in pancreatic adenocarcinoma cellsInternational Journal of Cancer, 2018
- Lipid-mediated muscle insulin resistance: different fat, different pathways?Journal of Molecular Medicine, 2015